Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Datapharm Australia has introduced a new initiative, known as DAI-SYS, aimed to bring together an international team of locally established contract research organizations (CROs) and specialist service providers to support global studies and clinical trials.
Subscribe to our email newsletter
Initiated in 2009, the concept has been designed to offer an alternative to global CROs and to reduce R&D costs, while leveraging local expertise and quality.
Enabling select local members to run clinical trials from anywhere across the globe, Dai-Sys is designed to offer a range of quality and cost effective solutions to sponsors.
Datapharm CEO Dr Helen Allars said Dai-Sys enables creation of a unique international industry co-operative to provide support to bio-product developers.
"Dai-Sys offers an innovative non-bureaucratic system that is cost competitive with lower overheads using local rates and high quality experienced local organizations- members are selected for their knowledge of local issues with a history of success," Allars added.
With representation in over 18 countries, and covered in Europe, Latin America, Australia and New Zealand, DAI-SYS CRO Plus links medium-sized to small experienced CROs together into a homogenous team offering an alternative to multinational CROs.
"Datapharm has many CRO friends globally, and we are currently in discussions with a number of companies regarding extending the Dai-Sys membership in Asia, Africa and North America" Dr Allars noted.
Currently, the CROs include Datapharm, MTZ Clinical Research, LatAm Clinical Trials, Larix and SynCro.